Alzheimer s Research & Therapy,
Год журнала:
2022,
Номер
14(1)
Опубликована: Янв. 28, 2022
Until
now,
Mendelian
randomization
(MR)
studies
have
investigated
the
causal
association
of
risk
factors
with
Alzheimer's
disease
(AD)
using
large-scale
AD
genome-wide
(GWAS),
GWAS
by
proxy
(GWAX),
and
meta-analyses
GWAX
(GWAS+GWAX)
datasets.
However,
it
currently
remains
unclear
about
consistency
MR
estimates
across
these
GWAS,
GWAX,
GWAS+GWAX
Here,
we
first
selected
162
independent
educational
attainment
genetic
variants
as
potential
instrumental
variables
(N
=
405,072).
We
then
one
dataset
63,926),
two
datasets
314,278
408,942),
three
388,324,
455,258,
472,868).
Finally,
conducted
a
analysis
to
evaluate
impact
on
Meanwhile,
tested
heterogeneity
In
dataset,
showed
that
each
SD
increase
in
years
schooling
(about
3.6
years)
was
significantly
associated
29%
reduced
(OR=0.71,
95%
CI:
0.60-0.84,
P=1.02E-04).
highlighted
increased
84%
(OR=1.84,
1.59-2.13,
P=4.66E-16).
suggested
ambiguous
findings
Heterogeneity
test
indicated
evidence
significant
difference
clinically
diagnosed
self-report
phenotype
GWAX.
Our
are
consistent
recent
variants.
Hence,
from
should
be
carefully
interpreted
warrant
further
investigation
dataset.
International Journal of Molecular Sciences,
Год журнала:
2021,
Номер
22(6), С. 2973 - 2973
Опубликована: Март 15, 2021
Tryptophan
is
an
essential
amino
acid
critical
for
protein
synthesis
in
humans
that
has
emerged
as
a
key
player
the
microbiota-gut-brain
axis.
It
only
precursor
neurotransmitter
serotonin,
which
vital
processing
of
emotional
regulation,
hunger,
sleep,
and
pain,
well
colonic
motility
secretory
activity
gut.
catabolites
from
kynurenine
degradation
pathway
also
modulate
neural
are
active
systemic
inflammatory
cascade.
Additionally,
tryptophan
its
metabolites
support
development
central
enteric
nervous
systems.
Accordingly,
dysregulation
plays
role
pathogenesis
many
neurologic
psychiatric
disorders.
Gut
microbes
influence
metabolism
directly
indirectly,
with
corresponding
changes
behavior
cognition.
The
gut
microbiome
thus
garnered
much
attention
therapeutic
target
both
disorders
where
play
prominent
role.
In
this
review,
we
will
touch
upon
some
these
features
their
involvement
health
disease.
Frontiers in Microbiology,
Год журнала:
2022,
Номер
12
Опубликована: Фев. 4, 2022
Evidence
supports
the
observational
associations
of
gut
microbiota
with
a
variety
psychiatric
disorders,
but
causal
nature
such
remains
obscure.
Aiming
to
comprehensively
investigate
their
relationship
and
identify
specific
microbe
taxa
for
diseases,
we
conducted
two-sample
Mendelian
randomization
(MR)
analysis
microbiome
15
diseases.
Specifically,
genome-wide
association
study
(GWAS)
in
18,473
individuals
from
MiBioGen
was
used
as
exposure
sample,
GWAS
diseases
outcome
samples.
One-hundred
ninety
bacterial
six
levels
were
available
analysis.
At
multiple-testing
corrected
significance
level
(phylum
P
<
5.56
×
10-3,
class
3.33
order
2.63
family
1.67
genus
4.90
10-4,
species
10-3),
following
eight
seven
features
(one
phylum
+
three
classes
one
species)
identified:
Prevotellaceae
autism
spectrum
disorder
(P
=
5.31
10-4),
Betaproteobacteria
bipolar
1.53
Actinobacteria
schizophrenia
1.33
Bacteroidia
Bacteroidales
Tourette
syndrome
2.51
10-3
extroversion
8.22
10-4
1.09
Clostridium
innocuum
neuroticism
8.92
10-4).
Sensitivity
showed
no
evidence
reverse
causality,
pleiotropy,
heterogeneity.
Our
findings
offered
novel
insights
into
microbiota-mediated
development
mechanism
disorders.
Nutrients,
Год журнала:
2021,
Номер
14(1), С. 20 - 20
Опубликована: Дек. 22, 2021
Alzheimer’s
disease
(AD)
is
the
most
common
form
of
neurodegenerative
disorders
affecting
mostly
elderly.
It
characterized
by
presence
Aβ
and
neurofibrillary
tangles
(NFT),
resulting
in
cognitive
memory
impairment.
Research
shows
that
alteration
gut
microbial
diversity
defects
brain
axis
are
linked
to
AD.
Probiotics
known
be
one
best
preventative
measures
against
decline
Numerous
vivo
trials
recent
clinical
have
proven
effectiveness
selected
bacterial
strains
slowing
down
progression
probiotics
modulate
inflammatory
process,
counteract
with
oxidative
stress,
modify
microbiota.
Thus,
this
review
summarizes
current
evidence,
strains,
AD,
harmful
for
mechanism
action
preventing
A
literature
search
on
databases
such
as
PubMed,
Semantic
Scholar,
Nature,
Springer
link
identified
potentially
relevant
articles
topic.
However,
upon
consideration
inclusion
criteria
limitation
publication
year,
only
22
been
further
reviewed.
The
query
includes
few
sets
keywords
follows.
(1)
OR
microbiome
microbes
AND
(2)
Alzheimer
aging
dementia
(3)
trial
animal
study.
results
evidenced
study
help
clearly
illustrate
relationship
between
probiotic
supplementation
systematic
will
identify
novel
therapeutic
strategies
future
free
from
triggering
any
adverse
effects
human
body.
Frontiers in Aging Neuroscience,
Год журнала:
2021,
Номер
13
Опубликована: Май 28, 2021
Alzheimer's
disease
(AD)
is
the
most
common
age-related
progressive
neurodegenerative
disease,
characterized
by
a
decline
in
cognitive
function
and
neuronal
loss,
caused
several
factors.
Numerous
clinical
experimental
studies
have
suggested
involvement
of
gut
microbiota
dysbiosis
patients
with
AD.
The
altered
can
influence
brain
behavior
through
microbiota-gut-brain
axis
via
various
pathways
such
as
increased
amyloid-β
deposits
tau
phosphorylation,
neuroinflammation,
metabolic
dysfunctions,
chronic
oxidative
stress.
With
no
current
effective
therapy
to
cure
AD,
modulation
may
be
promising
therapeutic
option
prevent
or
delay
onset
AD
counteract
its
progression.
Our
present
review
summarizes
alterations
pathogenetic
roles
mechanisms
microbiota-targeted
therapies
for
Understanding
between
will
help
decipher
pathogenesis
from
novel
perspectives
shed
light
on
strategies
Ageing Research Reviews,
Год журнала:
2022,
Номер
75, С. 101556 - 101556
Опубликована: Янв. 3, 2022
Alzheimer’s
disease
(AD)
is
the
most
common
cause
of
dementia,
accounting
for
more
than
50
million
patients
worldwide.
Current
evidence
suggests
exact
mechanism
behind
this
devastating
to
be
multifactorial
origin,
which
seriously
complicates
quest
an
effective
disease-modifying
therapy,
as
well
impedes
search
strategic
preventative
measures.
Of
interest,
preclinical
studies
point
serotonergic
alterations,
either
induced
via
selective
serotonin
reuptake
inhibitors
or
receptor
(ant)agonists,
in
mitigating
AD
brain
neuropathology
next
its
clinical
symptoms,
latter
being
supported
by
a
handful
human
intervention
trials.
Additionally,
substantial
amount
trials
highlight
potential
diet,
fecal
microbiota
transplantations,
pre-
and
probiotics
modulating
brain’s
neurotransmitter
system,
starting
from
gut.
Whether
such
interventions
could
truly
prevent,
reverse
slow
down
progression
likewise,
should
initially
tested
with
mouse
models,
including
sufficient
analytical
measurements
both
gut
brain.
Thereafter,
therapeutic
effect
confirmed
rigorously
randomized
controlled
humans,
preferentially
across
continuum,
but
especially
prodromal
up
mild
stages,
where
high
adherence
therapies,
room
noticeable
enhancement
are
feasible
still.
In
end,
might
aid
development
comprehensive
approach
tackle
complex
disease,
since
derivatives
microbiota-gut-brain
axis
serve
possible
biomarkers
progression,
forming
valuable
target
drug
development.
narrative
review,
available
concerning
orchestrating
role
within
summarized
discussed,
general
considerations
future
highlighted.
Frontiers in Immunology,
Год журнала:
2022,
Номер
13
Опубликована: Сен. 8, 2022
Background
Previous
researches
have
implicated
a
vital
association
between
gut
microbiota
(GM)
and
diabetic
retinopathy
(DR)
based
on
the
of
“gut-retina”
axis.
But
their
causal
relationship
has
not
been
elucidated.
Methods
Instrumental
variables
211
GM
taxa
were
obtained
from
genome
wide
study
(GWAS),
Mendelian
randomization
was
carried
out
to
estimate
effects
DR
risk
FinnGen
GWAS
(14,584
cases
202,082
controls).
Inverse
variance
weighted
(IVW)
is
main
method
analyze
causality,
MR
results
are
verified
by
several
sensitive
analyses.
Results
As
for
taxa,
IVW
confirmed
that
family-
Christensenellaceae
(
P
=
1.36×10
-2
)
Peptococcaceae
3.13×10
protective
factors
DR.
Genus-
Ruminococcaceae_UCG_011
4.83×10
-3
),
genus-
Eubacterium_rectale_group
3.44×10
Adlercreutzia
4.82×10
correlated
with
At
phylum,
class
order
levels,
we
found
no
causally
related
>0.05).
Heterogeneity
>0.05)
pleiotropy
analysis
robustness
results.
Conclusion
We
there
potential
some
DR,
which
highlights
axis
offered
new
insights
into
GM-mediated
mechanism
Further
explorations
required
will
lead
find
biomarkers
targeted
prevention
strategies
Journal of Alzheimer s Disease,
Год журнала:
2022,
Номер
87(1), С. 211 - 222
Опубликована: Март 8, 2022
Recent
studies
had
explored
that
gut
microbiota
was
associated
with
neurodegenerative
diseases
(including
Alzheimer's
disease
(AD),
Parkinson's
(PD),
and
amyotrophic
lateral
sclerosis
(ALS))
through
the
gut-brain
axis,
among
which
metabolic
pathways
played
an
important
role.
However,
underlying
causality
remained
unclear.Our
study
aimed
to
evaluate
potential
causal
relationships
between
microbiota,
metabolites,
Mendelian
randomization
(MR)
approach.We
selected
genetic
variants
traits
(N
=
18,340)
microbiota-derived
metabolites
7,824)
from
genome-wide
association
studies.
Summary
statistics
of
were
obtained
IGAP
(AD,
17,008
cases;
37,154
controls),
IPDGC
(PD,
37,688
141,779
IALSC
(ALS,
20,806
59,804
controls)
respectively.Greater
abundance
Ruminococcus
(OR,
1.245;
95%
CI,
1.103-1.405;
p
0.0004)
found
significantly
related
higher
risk
ALS.
Besides,
our
suggestive
associations
Actinobacteria,
Lactobacillaceae,
Faecalibacterium,
Ruminiclostridium,
Lachnoclostridium
AD,
Lentisphaerae,
Lentisphaeria,
Oxalobacteraceae,
Victivallales,
Bacillales,
Eubacteriumhalliigroup,
Anaerostipes,
Clostridiumsensustricto1
PD,
Lachnospira,
Fusicatenibacter,
Catenibacterium,
Ruminococcusgnavusgroup
Our
also
revealed
12
microbiome-dependent
diseases.
Glutamine
lower
AD.
For
serotonin
pathway,
as
a
protective
factor
while
kynurenine
for
ALS.Our
firstly
applied
two-sample
MR
approach
detect
findings
may
provide
new
targets
treatments
offer
valuable
insights
further
on
mechanisms.
Antioxidants,
Год журнала:
2023,
Номер
12(3), С. 676 - 676
Опубликована: Март 9, 2023
Depression
has
a
multifactorial
etiology
comprising
family
history
and
unemployment.
This
review
aims
to
summarize
the
evidence
available
for
antioxidant
anti-inflammatory
effects
of
carotenoids
in
mood
disorders.
article’s
methodologies
were
based
on
search
PubMed
database
all
linked
published
papers.
Epidemiological
studies
indicate
that
diet
rich
vegetables,
fruits,
nuts,
fish,
olive
oil
may
prevent
development
depression.
Antioxidant
supplementation
been
found
combat
various
stress-induced
psychiatric
disorders,
including
depression
anxiety.
A
growing
body
indicates
have
both
anti-inflammatory.
Studies
also
suggest
poor
dietary
intake,
particularly
low
intakes
fruit
vegetables
high
fast
food
other
convenience
foods,
increase
risk
developing
Thus,
interventions
potential
help
mitigate
mental
health
decline
general
population
those
with
Considering
effects,
it
is
expected
they
might
exert
promising
antidepressant
effect.
Nevertheless,
further
(including
interventional
mechanistic
studies)
assessing
effect
preventing
alleviating
symptoms
are
needed.
Molecular Psychiatry,
Год журнала:
2023,
Номер
28(4), С. 1611 - 1621
Опубликована: Март 13, 2023
Abstract
Clinical
and
animal
studies
have
shown
that
gut
microbiome
disturbances
can
affect
neural
function
behaviors
via
the
microbiota–gut–brain
axis,
may
be
implicated
in
pathogenesis
of
several
brain
diseases.
However,
exactly
how
modulates
nervous
system
activity
remains
obscure.
Here,
using
a
single-cell
nucleus
sequencing
approach,
we
sought
to
characterize
cell
type–specific
transcriptomic
changes
prefrontal
cortex
hippocampus
derived
from
germ-free
(GF),
specific
pathogen
free,
colonized-GF
mice.
We
found
absence
microbiota
resulted
cell-specific
changes.
Furthermore,
microglia
transcriptomes
were
preferentially
influenced,
which
could
effectively
reversed
by
microbial
colonization.
Significantly,
modulated
mutual
transformation
microglial
subpopulations
two
regions.
Cross-species
analysis
showed
transcriptome
these
mainly
associated
with
Alzheimer’s
disease
(AD)
major
depressive
disorder
(MDD),
further
supported
behavioral
tests.
Our
findings
demonstrate
modulate
subtypes,
lead
new
insights
into
AD
MDD.